Skip to content

Role of ASICs in Human Inflammatory Pain

Study of the Role of Acid Sensing Ion Channels (ASICs) in Human Inflammatory Pain

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01867840
Enrollment
20
Registered
2013-06-04
Start date
2018-01-01
Completion date
2024-06-05
Last updated
2026-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthritis, Chondrocalcinosis, Gouty Arthritis, Osteoarthritis, Rheumatoid Arthritis

Brief summary

In recent years, ion channels have emerged as new therapeutic targets for pain. Among these channels, ASICs (Acid Sensing Ion Channels) are of particular interest because they are directly activated by extracellular acidity, which is a major cause of pain. Indeed, many painful conditions such as ischemia, inflammation, tumor development or tissue incision are accompanied by tissue acidification. ASIC are excitatory ion channels that are expressed in neurons, including nociceptive sensory neurons. In humans, the use of amiloride, a nonspecific inhibitor of ASICs, has demonstrated their role in the perception of pain induced by subcutaneous injections of acidic solutions. ASICs thus appear as new candidates capable of mediating pain in humans. A growing number of data suggests that, in addition to protons, ASICs may also be activated by one or more endogenous compounds produced during inflammation. The purpose of this research project is to identify these compounds by testing the effects of human inflammatory exudates on ASICs activity. The discovery of such compounds would definitely validate ASICs as novel therapeutic targets for pain treatment in humans

Interventions

None listed

Sponsors

Centre Hospitalier Universitaire de Nice
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* septic arthritis * gonarthrosis in push-inflammatory * microcrystalline arthropathies * chronic inflammatory rheumatism

Exclusion criteria

* refusal to participate in the protocol

Design outcomes

Primary

MeasureTime frameDescription
activation or miodulation to Electrical potential of ionic channel in the synovial fluid1 dayonly once because it's an single ponction of sinovial fluid.

Countries

France

Contacts

PRINCIPAL_INVESTIGATORVéronique BREUIL, Pr

service de rhumatologie

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 18, 2026